Respiratory equipment has become an essential part of modern hospitals, intensive care units, emergency departments, operating rooms, and home-care settings. Today, healthcare facilities use a combination of ventilators, CPAP and BiPAP systems, oxygen therapy devices, respiratory masks, humidification systems, anesthesia equipment, and connected monitoring technologies.
Among the companies most frequently considered for these applications are ResMed, Philips, Fisher & Paykel Healthcare, Dräger, and GE HealthCare. Each has a different strength, so comparing their actual business scale and product focus is more useful than simply looking at brand recognition.
ResMed: Strong in Sleep and Breathing Care
ResMed is particularly well known for sleep-disordered breathing and home respiratory care. Its portfolio includes positive airway pressure devices, masks, ventilation systems, diagnostic technologies, and cloud-based software.
For fiscal 2025, ResMed reported $5.15 billion in total revenue, including $4.50 billion from Sleep and Breathing Health. Device revenue reached $2.67 billion, while masks and other products generated $1.84 billion.
| ResMed – FY2025 | Data |
|---|---|
| Total revenue | $5.15B |
| Sleep & Breathing Health | $4.50B |
| Device revenue | $2.67B |
| Masks & other | $1.84B |
| Residential Care Software | $641M |
For facilities focused on sleep apnea, non-invasive ventilation, and connected home respiratory care, ResMed is particularly relevant.
Philips: Broad Respiratory and Connected-Care Portfolio
Philips has historically been one of the most recognizable respiratory-care brands, with its Respironics portfolio covering sleep therapy and respiratory solutions.
Its 2025 reporting identifies Sleep & Respiratory Care as 19% of Connected Care sales and describes the business as covering diagnostics and therapy for sleep apnea and chronic respiratory conditions.
However, healthcare facilities evaluating Philips respiratory equipment in the U.S. need to consider its regulatory situation. Philips reported that more than 99% of registered CPAP and BiPAP devices affected by the 2021 recall had been remediated globally by December 2025. It also stated that, under the U.S. consent decree, Respironics was not selling new CPAP/BiPAP or other respiratory-care devices in the U.S. until specified requirements were met.
| Philips – 2025 | Data |
|---|---|
| Sleep & Respiratory Care share of Connected Care | 19% |
| Recalled CPAP/BiPAP devices remediated | >99% globally |
| Field-safety closures completed | 31 countries |
| Focus | Sleep & respiratory care |
Fisher & Paykel Healthcare: Strong in Respiratory Consumables
Fisher & Paykel Healthcare has a particularly strong position in respiratory humidification, nasal high-flow therapy, masks, and hospital respiratory-care consumables.
For the year ended March 2025, the company reported record operating revenue of $2.02 billion, up 16%. Its Hospital product group, which includes respiratory, acute, and surgical-care products, generated $1.28 billion, up 18%.
| Fisher & Paykel Healthcare – FY2025 | Data |
|---|---|
| Total operating revenue | $2.02B |
| Growth | 16% |
| Hospital product revenue | $1.28B |
| Hospital product growth | 18% |
| Key strength | Respiratory care & humidification |
This makes the company especially relevant when a hospital needs respiratory consumables and systems that support oxygen therapy, ventilation, and humidification.
Dräger: Intensive Care and Ventilation Expertise
Dräger has a long history in hospital respiratory and critical-care equipment. Its portfolio includes ventilators, anesthesia machines, patient monitoring technologies, and neonatal-care equipment.
In 2025, Dräger generated €3.482 billion in total sales and had 16,687 employees. Its medical division recorded €1.207 billion in sales, while medical order intake increased 8.9% to €2.047 billion, driven partly by demand for ventilators, anesthesia machines, services, and consumables.
| Dräger – 2025 | Data |
|---|---|
| Total sales | €3.48B |
| Medical business sales | €1.21B |
| Medical order intake | €2.05B |
| Employees | 16,687 |
| Development & production sites | 16 |
Its strongest fit is generally hospital-based critical care, intensive care, anesthesia, and neonatal applications.
GE HealthCare: Ventilation Within a Broader Hospital Portfolio
GE HealthCare is not exclusively a respiratory-equipment company, but its Patient Care Solutions portfolio includes life-support and ventilation technologies used in hospitals and operating rooms.
In 2025, GE HealthCare generated $20.63 billion in total revenue. Its Patient Care Solutions segment generated $3.09 billion, including $831 million from Life Support Solutions.
| GE HealthCare – 2025 | Data |
|---|---|
| Total revenue | $20.63B |
| Patient Care Solutions | $3.09B |
| Life Support Solutions | $831M |
| U.S. & Canada revenue | $9.53B |
| Total employees | Global healthcare organization |
This broader portfolio can be valuable for hospitals seeking respiratory equipment alongside patient monitoring, anesthesia, imaging, and other clinical technologies.
What Should Healthcare Facilities Compare?
The right respiratory equipment depends heavily on the clinical environment. An ICU may prioritize invasive and non-invasive ventilators, while a sleep center may focus on CPAP, BiPAP, masks, and connected software.
Hospitals should therefore compare ventilation modes, oxygen-delivery capability, humidification, patient monitoring, interoperability, consumables, maintenance support, training, regulatory status, and total cost of ownership.
Important Links
Get a personalized dashboard built around your niche; with the exact data and insights you need. Request for a demo: https://www.towardshealthcare.com/access-dashboard
About Us
Towards Healthcare Research & Consulting is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
Connect with us for more enquiry at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium